Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Otto

Showing results (481-490 of 541) with videos related to

Pageof 55
Sort By:
The Journal of Clinical Psychiatry|May 3, 2006
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorderMark H Pollack, Naomi M Simon, Andrea Fagiolini, et al.
Journal of Psychiatric Research|October 21, 2006
The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorderNaomi M Simon, Alyson K Zalta, Michael W Otto, et al.
Cognitive Behaviour Therapy|April 29, 2020
Age and pre quit-day attrition during smoking cessation treatmentHaley E Conroy, Jolene Jacquart, Scarlett O Baird, et al.
The Journal of Clinical Psychiatry|March 20, 2008
Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapyNaomi M Simon, Kathryn M Connor, Ariel J Lang, et al.
Journal of Affective Disorders|August 11, 2012
Cognitive therapy for anxious depression in STAR(*) D: what have we learned?Amy Farabaugh, Jonathan Alpert, Stephen R Wisniewski, et al.
The Journal of Clinical Psychiatry|March 8, 2012
Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trialKari R Nations, Jasper A J Smits, David F Tolin, et al.
Journal of Psychiatric Research|July 3, 2023
Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBTRebecca E Lubin, Hayley E Fitzgerald, David Rosenfield, et al.
The Australian and New Zealand Journal of Psychiatry|July 27, 2018
The impact of substance use disorders on recovery from bipolar depression: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder psychosocial treatment trialAlexandra K Gold, Amy T Peters, Michael W Otto, et al.
Mental Health and Physical Activity|October 12, 2016
Exercise Self-Efficacy Moderates the Relation between Anxiety Sensitivity and Body Mass Index and Exercise Tolerance in Treatment-Seeking SmokersSamantha G Farris, Michelle L Davis, David Rosenfield, et al.
Drug and Alcohol Dependence|February 1, 2020
Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trialJasper A J Smits, Michael J Zvolensky, Michael W Otto, et al.
Pageof 55

Showing results (481-490 of 541) with videos related to

Sort By:
Pageof 55
The Journal of Clinical Psychiatry|May 3, 2006
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorderMark H Pollack, Naomi M Simon, Andrea Fagiolini, et al.
Journal of Psychiatric Research|October 21, 2006
The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorderNaomi M Simon, Alyson K Zalta, Michael W Otto, et al.
Cognitive Behaviour Therapy|April 29, 2020
Age and pre quit-day attrition during smoking cessation treatmentHaley E Conroy, Jolene Jacquart, Scarlett O Baird, et al.
The Journal of Clinical Psychiatry|March 20, 2008
Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapyNaomi M Simon, Kathryn M Connor, Ariel J Lang, et al.
Journal of Affective Disorders|August 11, 2012
Cognitive therapy for anxious depression in STAR(*) D: what have we learned?Amy Farabaugh, Jonathan Alpert, Stephen R Wisniewski, et al.
The Journal of Clinical Psychiatry|March 8, 2012
Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trialKari R Nations, Jasper A J Smits, David F Tolin, et al.
Journal of Psychiatric Research|July 3, 2023
Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBTRebecca E Lubin, Hayley E Fitzgerald, David Rosenfield, et al.
The Australian and New Zealand Journal of Psychiatry|July 27, 2018
The impact of substance use disorders on recovery from bipolar depression: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder psychosocial treatment trialAlexandra K Gold, Amy T Peters, Michael W Otto, et al.
Mental Health and Physical Activity|October 12, 2016
Exercise Self-Efficacy Moderates the Relation between Anxiety Sensitivity and Body Mass Index and Exercise Tolerance in Treatment-Seeking SmokersSamantha G Farris, Michelle L Davis, David Rosenfield, et al.
Drug and Alcohol Dependence|February 1, 2020
Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trialJasper A J Smits, Michael J Zvolensky, Michael W Otto, et al.
Pageof 55